Recently, Hangzhou Boric Technology Co., Ltd. (referred to as Boric Technology) underwent a hearing at the Hong Kong Stock Exchange. The company was established in 2002 and mainly focuses on the design, development, production, and sale of three types of PCR products: instruments, reagents, and consumables. In 2020, driven by the catalytic effect of the epidemic, the company's revenue increased by 757% year-on-year to 1.234 billion yuan, and net income increased by 623% year-on-year to 0.217 billion yuan.
$BIOER TECHNOLOGY (810281.HK)$
Source | Wise Finance Editor | Arti
This article is for informational purposes only and does not constitute any trading advice.
From the perspective of the industry chain, Bori Technology is a life science instrument and reagent company that covers almost the entire PCR product industry value chain.
It is understood that the company mainly designs, develops, produces, and sells three types of PCR products, namely instruments, reagents, and consumables. Among them, instruments include equipment for extracting and purifying DNA and RNA in samples, equipment for performing PCR reactions, and equipment for detecting and analyzing reaction results; reagents include sample preservation solution for preserving DNA and RNA in samples, reagents for extracting and purifying DNA and RNA in samples, and reagents for nucleic acid qualitative or quantitative detection; consumables include instrument-specific consumables and general molecular detection consumables.
When it comes to specific products...